Buyer: Water Street Healthcare Partners
Seller: Alliance Life Sciences & Health Strategies Group
Sector: Healthcare, Population Health, Health IT
CHICAGO–(BUSINESS WIRE)–Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry, announced today that it has completed two acquisitions to build a leading global life sciences’ commercialisation services platform. The health care firm has acquired Alliance Life Sciences (Alliance) and Health Strategies Group. Water Street will bring the two companies together with The Access Group, a business it acquired last year, under a global enterprise that will offer life sciences companies a suite of commercialisation services to support them with bringing new therapies to market, and gaining and sustaining market access and share.
“We are excited to be at the forefront of helping life sciences firms develop, manage and deliver new outcomes-based therapies that address specific patient populations and diseases”
“We are excited to be at the forefront of helping life sciences firms develop, manage and deliver new outcomes-based therapies that address specific patient populations and diseases,” said Jim Lang, an executive adviser with Water Street who will serve as executive chairman of the newly combined enterprise. “By bringing these two market-leading companies together with The Access Group, we are taking the next step toward building a global leader that will offer life sciences companies an integrated portfolio of solutions to help them bring the right therapies to the right patients at the right value.”
Alliance, founded in 2008, specialises in maximising revenue and optimising pricing for its customers. The firm offers a broad array of global pricing analytic tools and data, outsourced contract and revenue management services, including business process outsourcing, and digital marketing operational services.
Founded in 1992, Health Strategies Group is the leader in market access intelligence and customised research for pharmaceutical and biotech professionals. Its team of analysts dissects trends and identifies opportunities to help companies optimise their product access and distribution.
Emmanuel Doe, CEO, Alliance, stated: “Together with Health Strategies Group and The Access Group, we will offer our customers a deeper and more extensive portfolio of next-generation solutions that address the entire spectrum of their commercial needs. As one entity, we will have a greater impact on aligning outcomes among patients, caregivers, physicians and payers for pharmaceutical and medical device products.”
Alan Crowther, president of global markets, Alliance, added: “Our clients are working incredibly fast and hard to bring new and life-changing therapies to market. Building this new platform with Water Street enables us to combine our software development, data management and business process outsourcing capabilities with new services that will accelerate getting these therapies to the patients who need them.”
Water Street’s new global enterprise will work with life sciences companies to introduce new therapies and optimise existing therapies to targeted patient populations through the following suite of solutions:
Strategic and Advisory Consulting Services
Agency Implementation and Execution
Research, Data and Analytics Products
Turnkey Outsourced Operations
Alliance, Health Strategies Group and The Access Group will continue to operate under their current names and leadership teams. The executives of each company will report to the holding company’s board of directors spearheaded by Executive Chairman Jim Lang.
Financial details of the acquisitions are not being disclosed.
Another noteworthy transaction as healthcare M&A continues to increase across many medical provider, distribution and supply sectors. For more information, contact us at Paragon Ventures LLC – Healthcare Mergers and Strategic Acquisitions at 800-719-1555 or visit our website at www.paragonventures.com